SEP
EMN icon

Signature Equity Partners’s Eastman Chemical EMN Stock Holding History

Signature Equity Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49
Closed -$3.13K – 1577
2025
Q4 		$3.13K Buy
+49
New +$3.02K ﹤0.01% 1108

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Signature Equity Partners's EMN Position: Q1 2026 in Review

Signature Equity Partners sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 49 shares — an estimated $3.13K sold.

Signature Equity Partners first reported a position in EMN in Q4 2025 and held it in 1 quarter. The position peaked at $3.13K in Q4 2025. 640 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Signature Equity Partners reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
  • Signature Equity Partners sold 49 Eastman Chemical shares in Q1 2026, an estimated $3.13K.
  • Signature Equity Partners first reported a position in Eastman Chemical in Q4 2025 and held it in 1 quarter.
  • Signature Equity Partners's Eastman Chemical position peaked at $3.13K in Q4 2025.
  • 640 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.